AORT
Cryolife Inc is engaged in medical device manufacturing and distribution and in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It has two segments: Medical Devices and Preservation Services.
Artivion, Inc. (AORT) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Momentum (C-). The rating has held at C+ for 6 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | C+ (2.7) | C+ (2.6) | B (3.2) | C- (1.9) | C+ (2.6) | C+ (2.6) |
| 2026-11-10 | C+ (2.5) | C (2.4) | B (3.2) | C- (2.0) | C+ (2.6) | C+ (2.6) |
| 2026-11-03 | C+ (2.7) | B- (3.0) | B (3.2) | C- (2.0) | C+ (2.7) | C+ (2.7) |
| 2026-10-27 | C+ (2.7) | B- (3.0) | B (3.2) | D+ (1.7) | C+ (2.6) | C+ (2.7) |
| 2026-10-20 | C+ (2.8) | B- (3.0) | B (3.2) | C- (1.9) | C+ (2.6) | C+ (2.7) |